Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 382,195 | 291,244 | 284,900 | 294,588 |
| General And Administrative Expense | 382,195 | 291,244 | 284,900 | 294,588 |
| Operating Expense | 382,195 | 291,244 | 284,900 | 294,588 |
| Operating Income | -382,195 | -291,244 | -284,900 | -294,588 |
| EBIT | -382,195 | -291,244 | -284,900 | -294,588 |
| Interest Income | 83.00 | 855.00 | 0.00 | 0.00 |
| Interest Income Non Operating | 83.00 | 855.00 | 0.00 | 0.00 |
| Net Interest Income | 83.00 | 855.00 | 0.00 | 0.00 |
| Other Income Expense | -559,853 | 265,000 | -- | 155,829 |
| Special Income Charges | -559,853 | 265,000 | 0.00 | 155,829 |
| Restructuring And Mergern Acquisition | 0.00 | -300,000 | 0.00 | -- |
| Pretax Income | -941,965 | -25,389 | -284,900 | -138,759 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -941,965 | -25,389 | -284,900 | -138,759 |
| Net Income From Continuing Operation Net Minority Interest | -941,965 | -25,389 | -284,900 | -138,759 |
| Net Income Including Noncontrolling Interests | -941,965 | -25,389 | -284,900 | -138,759 |
| Net Income Common Stockholders | -941,965 | -25,389 | -284,900 | -138,759 |
| Net Income | -941,965 | -25,389 | -284,900 | -138,759 |
| EBITDA | -382,195 | -291,244 | -284,900 | -294,588 |
| Normalized EBITDA | 177,658 | -556,244 | -284,900 | -450,417 |
| Basic EPS | -0.03 | 0.00 | -0.01 | -0.01 |
| Diluted EPS | -0.03 | 0.00 | -0.01 | -0.01 |
| Basic Average Shares | 29.9M | 25.7M | 25.7M | 25.7M |
| Diluted Average Shares | 29.9M | 25.7M | 25.7M | 25.7M |
| Total Unusual Items | -559,853 | 265,000 | 0.00 | 155,829 |
| Total Unusual Items Excluding Goodwill | -559,853 | 265,000 | 0.00 | 155,829 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -382,112 | -290,389 | -284,900 | -294,588 |
| Diluted NI Availto Com Stockholders | -941,965 | -25,389 | -284,900 | -138,759 |
| Gain On Sale Of Ppe | -- | -- | 0.00 | 353,791 |
| Impairment Of Capital Assets | 609,853 | 35,000 | 0.00 | 197,962 |
| Net Income Continuous Operations | -941,965 | -25,389 | -284,900 | -138,759 |
| Net Non Operating Interest Income Expense | 83.00 | 855.00 | 0.00 | 0.00 |
| Other Gand A | 311,252 | 291,244 | 284,900 | 294,588 |
| Other Special Charges | -50,000 | -- | -- | -- |
| Salaries And Wages | 70,943 | 0.00 | -- | -- |
| Total Expenses | 382,195 | 291,244 | 284,900 | 294,588 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 410,287 | 271,148 | 244,875 | 739,392 |
| Cash Cash Equivalents And Short Term Investments | 410,287 | 271,148 | 244,875 | 739,392 |
| Cash Financial | 410,287 | 271,148 | 244,875 | 739,392 |
| Receivables | 6,933 | 7,142 | 41,465 | 15,853 |
| Prepaid Assets | 4,875 | 14,524 | 16,842 | 0.00 |
| Current Assets | 422,095 | 292,814 | 303,182 | 755,245 |
| Net PPE | 475,416 | 1.2M | 1.2M | 1.1M |
| Total Non Current Assets | 475,416 | 1.2M | 1.2M | 1.1M |
| Total Assets | 897,511 | 1.5M | 1.5M | 1.9M |
| Payables And Accrued Expenses | 28,437 | 21,097 | 17,605 | 137,190 |
| Current Liabilities | 28,437 | 21,097 | 17,605 | 137,190 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 28,437 | 21,097 | 17,605 | 137,190 |
| Common Stock | 10.7M | 10.4M | 10.4M | 10.4M |
| Capital Stock | 10.7M | 10.4M | 10.4M | 10.4M |
| Retained Earnings | -11.4M | -10.4M | -10.4M | -10.1M |
| Common Stock Equity | 869,074 | 1.4M | 1.5M | 1.8M |
| Stockholders Equity | 869,074 | 1.4M | 1.5M | 1.8M |
| Total Equity Gross Minority Interest | 869,074 | 1.4M | 1.5M | 1.8M |
| Total Capitalization | 869,074 | 1.4M | 1.5M | 1.8M |
| Net Tangible Assets | 869,074 | 1.4M | 1.5M | 1.8M |
| Tangible Book Value | 869,074 | 1.4M | 1.5M | 1.8M |
| Working Capital | 393,658 | 271,717 | 285,577 | 618,055 |
| Invested Capital | 869,074 | 1.4M | 1.5M | 1.8M |
| Share Issued | 31.7M | 25.7M | 25.7M | 25.7M |
| Ordinary Shares Number | 31.7M | 25.7M | 25.7M | 25.7M |
| Other Equity Interest | 1.5M | 1.5M | 1.5M | 1.5M |
| Other Receivables | 6,933 | 7,142 | 41,465 | 15,853 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -243,971 | 49,744 | -446,939 | -171,488 |
| Cash Flow From Continuing Operating Activities | -243,971 | 49,744 | -446,939 | -171,488 |
| Stock Based Compensation | 70,943 | 0.00 | -- | -- |
| Change In Working Capital | 17,198 | 40,133 | -162,039 | 123,100 |
| Change In Receivables | 209.00 | 34,323 | -25,612 | 12,266 |
| Change In Payables And Accrued Expense | 7,340 | 3,492 | -119,585 | 110,834 |
| Capital Expenditure | -16,890 | -23,471 | -47,578 | -210,202 |
| Purchase Of PPE | -- | -- | -- | -210,202 |
| Net PPE Purchase And Sale | 100,000 | 0.00 | -- | -210,202 |
| Sale Of Investment | -- | -- | 0.00 | 446,283 |
| Net Investment Purchase And Sale | -- | -- | 0.00 | 446,283 |
| Investing Cash Flow | 83,110 | -23,471 | -47,578 | 236,081 |
| Cash Flow From Continuing Investing Activities | 83,110 | -23,471 | -47,578 | 236,081 |
| Issuance Of Capital Stock | 300,000 | 0.00 | -- | -- |
| Net Common Stock Issuance | 300,000 | 0.00 | -- | -- |
| Financing Cash Flow | 300,000 | 0.00 | -- | 0.00 |
| Cash Flow From Continuing Financing Activities | 300,000 | 0.00 | -- | 0.00 |
| Changes In Cash | 139,139 | 26,273 | -494,517 | 64,593 |
| Beginning Cash Position | 271,148 | 244,875 | 739,392 | 674,799 |
| End Cash Position | 410,287 | 271,148 | 244,875 | 739,392 |
| Free Cash Flow | -260,861 | 26,273 | -494,517 | -381,690 |
| Income Tax Paid Supplemental Data | 0.00 | 0.00 | -- | -- |
| Asset Impairment Charge | 609,853 | 35,000 | 0.00 | 197,962 |
| Capital Expenditure Reported | -16,890 | -23,471 | -47,578 | -210,202 |
| Change In Prepaid Assets | 9,649 | 2,318 | -16,842 | 0.00 |
| Common Stock Issuance | 300,000 | 0.00 | -- | -- |
| Gain Loss On Sale Of PPE | -- | -- | 0.00 | -353,791 |
| Net Income From Continuing Operations | -941,965 | -25,389 | -284,900 | -138,759 |
| Net Other Investing Changes | -- | -- | -47,578 | 200,000 |
| Operating Gains Losses | -- | -- | -- | -353,791 |
| Proceeds From Stock Option Exercised | -- | -- | -- | 0.00 |
| Sale Of PPE | 100,000 | 0.00 | -- | -- |